Pointing to an almost one per cent growth in three-month revenues which totalled $367 million, CEO Audley Reid said though ...

Increase in refrigerated warehouses and the rise in growth of the processed food and Pharmaceutical sectors drive the global cold chain logistics market.

Creating a well-integrated, resilient, and highly transparent supply chain is central to effective and safe patient ... the health condition and how it is managed. That process may start and end with ...

EY's Arda Ural provides an assessment of the current life sciences business environment, and reasons for optimism about 2025 despite the uncertainty that comes with a new administration in the U.S.

The Chairman of the Pharmaceutical Manufacturers Group ... into their account as against VAT taxing at the end of the year? Or are we to start from the day that the implementation order begins?

There are many challenges in the pharmaceutical supply chain, from maintaining quality to security issues. Can blockchain provide the end-to-end visibility needed? It’s a good time for the ...

It’s likely to still be there at the end of the year, but by the time the final sales figures for 2024 are tallied up, Novo ...

Ashland is a promising investment with a potential 58.3% upside, strong financials, and growth in biotechnology.

Since 2021, the biotech and pharmaceutical sectors have had their sustainability performances closely monitored. Near the end of every year ... resource-intensive – actually come from the lab supply ...

Ensuring the supply ... pharmaceutical supply chains by providing a complete end-to-end solution that tracks shipments from production to administration. The system’s ability to guarantee the safety ...

according to one study at the start of this year. Reorientating the pharmaceutical supply chain has many benefits, but it doesn’t come without its challenges either. So, could reshoring offer ...